Literature DB >> 15134542

SATE pronucleotide approaches: an overview.

S Peyrottes1, D Egron, I Lefebvre, G Gosselin, J-L Imbach, C Périgaud.   

Abstract

This review depicts in vitro and in vivo results obtained with nucleotide prodrugs (pronucleotides) bearing S-acyl-2-thioethyl (SATE) groups as esterase-labile phosphate protections. New developments are illustrated by the design of mononucleoside mixed phosphoester derivatives leading to the selective intracellular delivery of the corresponding 5'-mononucleotide through two different enzyme-mediated activation steps.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134542     DOI: 10.2174/1389557043404007

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  13 in total

1.  Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.

Authors:  Carlos M Galmarini; Galya Warren; Madapathage T Senanayake; Serguei V Vinogradov
Journal:  Int J Pharm       Date:  2010-05-24       Impact factor: 5.875

2.  Molecular tools for cell and systems biology.

Authors:  Carsten Schultz
Journal:  HFSP J       Date:  2007-11-29

Review 3.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

Review 4.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

5.  Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.

Authors:  Bryan R Meade; Khirud Gogoi; Alexander S Hamil; Caroline Palm-Apergi; Arjen van den Berg; Jonathan C Hagopian; Aaron D Springer; Akiko Eguchi; Apollo D Kacsinta; Connor F Dowdy; Asaf Presente; Peter Lönn; Manuel Kaulich; Naohisa Yoshioka; Edwige Gros; Xian-Shu Cui; Steven F Dowdy
Journal:  Nat Biotechnol       Date:  2014-11-17       Impact factor: 54.908

Review 6.  Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues.

Authors:  Larryn W Peterson; Charles E McKenna
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

7.  Evolution of an amino acid based prodrug approach: stay tuned.

Authors:  Ivan S Krylov; Boris A Kashemirov; John M Hilfinger; Charles E McKenna
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

8.  Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.

Authors:  Carlos M Galmarini; Galya Warren; Ekta Kohli; Arin Zeman; Anton Mitin; Serguei V Vinogradov
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

9.  5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activity.

Authors:  T Santhosh Kumar; Tiehong Yang; Shilpi Mishra; Chunxia Cronin; Saibal Chakraborty; Jian-Bing Shen; Bruce T Liang; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

10.  Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys.

Authors:  Lucie Durand-Gasselin; Koen K A Van Rompay; Jennifer E Vela; Ilana N Henne; William A Lee; Gerry R Rhodes; Adrian S Ray
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.